- Nicotinamide N-Methyltransferase Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric Cancer
Miaowei Wu et al, 2020, Frontiers in Genetics CrossRef - Nicotinamide N-Methyltransferase: A Promising Biomarker and Target for Human Cancer Therapy
Xiao-Yu Li et al, 2022, Frontiers in Oncology CrossRef - Beyond Nicotinamide Metabolism: Potential Role of Nicotinamide N-Methyltransferase as a Biomarker in Skin Cancers
Roberto Campagna et al, 2021, Cancers CrossRef - NNMT Is an Immune-Related Prognostic Biomarker That Modulates the Tumor Microenvironment in Pan-Cancer
Wenxiu Liu et al, 2023, Disease Markers CrossRef - Proteomic Changes in the Monolayer and Spheroid Melanoma Cell Models of Acquired Resistance to BRAF and MEK1/2 Inhibitors
Ramon Martinez et al, 2022, ACS Omega CrossRef - Decoding the Immune Microenvironment of Clear Cell Renal Cell Carcinoma by Single-Cell Profiling to Aid Immunotherapy
Jie Liu et al, 2022, Frontiers in Immunology CrossRef - A tEMTing target? Clinical and experimental evidence for epithelial-mesenchymal transition in the progression of cutaneous squamous cell carcinoma (a scoping systematic review)
Benjamin Genenger et al, 2022, Discover Oncology CrossRef - Investigating Cutaneous Squamous Cell Carcinoma in vitro and in vivo: Novel 3D Tools and Animal Models
Marika Quadri et al, 2022, Frontiers in Medicine CrossRef - Methylosystem for Cancer Sieging Strategy
Shotaro Tatekawa et al, 2021, Cancers CrossRef - Apprising Diagnostic and Prognostic Biomarkers in Cutaneous Melanoma—Persistent Updating
Simona Roxana Georgescu et al, 2022, Journal of Personalized Medicine CrossRef